Agiloft CLM
Key Info:
Details
Agiloft CLM is a cloud contract lifecycle management platform for organisations that need configurable contract processes across creation, negotiation, approval and post-signature management. Its published positioning focuses on making contract data and workflows adaptable to the policies and operational requirements of a particular organisation.
The product supports contract creation, negotiation, approval chains, obligation tracking and renewal management. Teams can configure processes around request intake, templates, routing and review rather than relying on a single fixed workflow. The vendor also describes contract data management, reporting and automation capabilities intended to support the stages from request through value recognition. These functions can be relevant where a business needs to model different approval paths or contract types in one system.
Agiloft is aimed at legal, procurement and enterprise operations teams. The platform is cloud delivered. It may be considered by organisations with established contract processes that need configuration and governance, but the practical scope of an implementation will depend on the contract types, workflow complexity, integrations and data migration requirements.
Public vendor material confirms the contract lifecycle, configuration, negotiation, approval, obligation and renewal capabilities described on this card. This review does not publish pricing, API availability, supported languages, device applications, operating-system support or company-size recommendations because they were not independently confirmed. Information was checked on 29 July 2026.
Buyers comparing this product with other contract tools should confirm the supported contract types, approval paths, user roles, data migration, data residency, security controls, integrations, implementation services, reporting needs and governance model. These criteria can materially affect fit but are not rated on this card. BBS does not infer them from marketing material or from comparable products without primary evidence.